Covered recipient · General Payments record
GEORGE YAGHMOUR
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2024 · Entire year
$471,123.79
401 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2024 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $310,830.50 | 75 |
| Travel and Lodging | $68,950.20 | 131 |
| Honoraria | $43,085.00 | 16 |
| Consulting Fee | $37,583.00 | 15 |
| Food and Beverage | $10,571.09 | 162 |
| Education | $104.00 | 2 |
By paying entity
PY2024 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $69,105.47 | 42 |
| JAZZ PHARMACEUTICALS INC. | $54,371.35 | 41 |
| E.R. Squibb & Sons, L.L.C. | $53,994.41 | 36 |
| Astellas Pharma US Inc | $48,788.62 | 35 |
| Rigel Pharmaceuticals, Inc. | $41,560.85 | 23 |
| SOBI, INC | $36,190.16 | 17 |
| Blueprint Medicines Corporation | $35,015.96 | 35 |
| Stemline Therapeutics Inc. | $24,923.40 | 17 |
| Alexion Pharmaceuticals, Inc. | $23,789.58 | 20 |
| Incyte Corporation | $21,056.52 | 20 |
| Kite Pharma, Inc. | $14,020.06 | 17 |
| Novartis Pharmaceuticals Corporation | $9,720.98 | 26 |
| ABBVIE INC. | $9,456.72 | 11 |
| Secura Bio, Inc. | $8,353.72 | 7 |
| SERVIER PHARMACEUTICALS LLC | $5,919.96 | 9 |
| Daiichi Sankyo Inc. | $5,682.33 | 12 |
| AstraZeneca Pharmaceuticals LP | $3,139.97 | 11 |
| Gamida Cell Inc. | $2,550.00 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,602.21 | 2 |
| Amgen Inc. | $750.00 | 1 |
| Celgene Corporation | $657.62 | 6 |
| BeiGene USA, Inc. | $174.18 | 2 |
| PFIZER INC. | $134.52 | 4 |
| GENZYME CORPORATION | $65.22 | 3 |
| Legend Biotech USA Inc. | $45.39 | 1 |
| Janssen Scientific Affairs, LLC | $31.67 | 1 |
| Janssen Biotech, Inc. | $22.92 | 1 |
Page 4 of 9; records 151–200 of 401 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
GEORGE YAGHMOUR
NPI 1669604849 · CMS profile ID 2784710
Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology
LOS ANGELES, CA
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 4 of 9; records 151–200 of 401 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1669604849?year=2024&recipient=provider&page=4#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- GEORGE YAGHMOUR, NPI 1669604849, CMS profile ID 2784710. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 9; records 151–200 of 401 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1669604849?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
- APA 7
- IndustryPayments. (2026). GEORGE YAGHMOUR, NPI 1669604849, CMS profile ID 2784710. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 9; records 151–200 of 401 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1669604849?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
- Bluebook
- GEORGE YAGHMOUR, NPI 1669604849, CMS profile ID 2784710, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 9; records 151–200 of 401 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1669604849?year=2024&recipient=provider&page=4#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2024
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30
401 matching records · $471,123.79 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 151–200 of 401.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,497.50 | 07/23/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1105639774 | CMS |
| JAZZ PHARMACEUTICALS INC. | $185.25 | 07/20/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1150226388 | CMS |
| JAZZ PHARMACEUTICALS INC. | $185.25 | 07/20/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1150226458 | CMS |
| Alexion Pharmaceuticals, Inc. | $9.00 | 07/19/2024 | Education | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1093964346 | CMS |
| JAZZ PHARMACEUTICALS INC. | $121.02 | 07/19/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1150226446 | CMS |
| JAZZ PHARMACEUTICALS INC. | $1,601.35 | 07/19/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1150226460 | CMS |
| JAZZ PHARMACEUTICALS INC. | $129.10 | 07/19/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1150226462 | CMS |
| Secura Bio, Inc. | $1,650.00 | 07/18/2024 | Honoraria | No dispute reported | Delay: No Change: CHANGED | 06/30/2026 | 1133336780 | CMS |
| ABBVIE INC. | $19.51 | 07/16/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1106368199 | CMS |
| JAZZ PHARMACEUTICALS INC. | $150.48 | 07/16/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1150226448 | CMS |
| JAZZ PHARMACEUTICALS INC. | $150.48 | 07/16/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1150226464 | CMS |
| AstraZeneca Pharmaceuticals LP | $74.68 | 07/13/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1104399715 | CMS |
| AstraZeneca Pharmaceuticals LP | $43.78 | 07/13/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1104667563 | CMS |
| AstraZeneca Pharmaceuticals LP | $359.65 | 07/13/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1104672109 | CMS |
| AstraZeneca Pharmaceuticals LP | $45.00 | 07/13/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1104782364 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.29 | 07/13/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1105844503 | CMS |
| Daiichi Sankyo Inc. | $58.99 | 07/11/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089500192 | CMS |
| Daiichi Sankyo Inc. | $57.01 | 07/11/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089500196 | CMS |
| Daiichi Sankyo Inc. | $71.28 | 07/11/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089500198 | CMS |
| E.R. Squibb & Sons, L.L.C. | $5,082.00 | 07/11/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1101503863 | CMS |
| Daiichi Sankyo Inc. | $258.13 | 07/10/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089500194 | CMS |
| GlaxoSmithKline, LLC. | $3,262.50 | 07/09/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1116010316 | CMS |
| SERVIER PHARMACEUTICALS LLC | $1,530.00 | 07/09/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1147259790 | CMS |
| E.R. Squibb & Sons, L.L.C. | $6,987.00 | 07/08/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1101503791 | CMS |
| E.R. Squibb & Sons, L.L.C. | $3,176.00 | 07/02/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1101503798 | CMS |
| SOBI, INC | $5,200.00 | 07/02/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1141438723 | CMS |
| SOBI, INC | $122.53 | 07/02/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1141438725 | CMS |
| Blueprint Medicines Corporation | $80.00 | 07/01/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1147447688 | CMS |
| Blueprint Medicines Corporation | $247.96 | 07/01/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1147447690 | CMS |
| Blueprint Medicines Corporation | $215.50 | 07/01/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1147447694 | CMS |
| Blueprint Medicines Corporation | $267.72 | 07/01/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1147447698 | CMS |
| PFIZER INC. | $0.66 | 07/01/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1132054906 | CMS |
| PFIZER INC. | $18.25 | 06/30/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1131676995 | CMS |
| Blueprint Medicines Corporation | $212.71 | 06/28/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1147447692 | CMS |
| Blueprint Medicines Corporation | $237.52 | 06/28/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1147447696 | CMS |
| GENZYME CORPORATION | $22.94 | 06/28/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1139855267 | CMS |
| JAZZ PHARMACEUTICALS INC. | $283.48 | 06/28/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1150226450 | CMS |
| JAZZ PHARMACEUTICALS INC. | $283.48 | 06/28/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1150226454 | CMS |
| Blueprint Medicines Corporation | $105.07 | 06/27/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1147447700 | CMS |
| Rigel Pharmaceuticals, Inc. | $6,028.00 | 06/27/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1145202736 | CMS |
| Kite Pharma, Inc. | $2,650.00 | 06/26/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1128612089 | CMS |
| Novartis Pharmaceuticals Corporation | $113.50 | 06/26/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1087427260 | CMS |
| Kite Pharma, Inc. | $34.75 | 06/25/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1128612087 | CMS |
| E.R. Squibb & Sons, L.L.C. | $149.98 | 06/20/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1101503856 | CMS |
| E.R. Squibb & Sons, L.L.C. | $587.81 | 06/20/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1101503859 | CMS |
| E.R. Squibb & Sons, L.L.C. | $458.87 | 06/20/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1101503867 | CMS |
| E.R. Squibb & Sons, L.L.C. | $275.72 | 06/20/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1101503871 | CMS |
| GlaxoSmithKline, LLC. | $7.04 | 06/19/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1116707527 | CMS |
| E.R. Squibb & Sons, L.L.C. | $124.16 | 06/13/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1101503783 | CMS |
| E.R. Squibb & Sons, L.L.C. | $647.66 | 06/13/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1101503787 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $119,401.38 | 2 |
| PY2023 | Principal investigator | $418.43 | 2 |
| PY2022 | Principal investigator | $88,039.00 | 13 |
| PY2021 | Principal investigator | $116,457.00 | 21 |
| PY2020 | Principal investigator | $255,184.18 | 43 |
| PY2019 | Principal investigator | $378,138.18 | 25 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
2 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | Syndax Pharmaceuticals, Inc. | $500.00 | 12/04/2025 | Non-covered Recipient Entity UNIVERSITY OF SOUTHERN CALIFORNIA | A PHASE 1/2, OPEN-LABEL, DOSE-ESCALATION AND DOSE-EXPANSION COHORT STUDY OF SNDX-5613 IN PATIENTS WITH RELAPSED/REFRACTORY LEUKEMIAS, INCLUDING THOSE HARBORING AN MLL/KMT2A GENE REARRANGEMENT OR NUCLEOPHOSMIN 1 (NPM1) MUTATION | No dispute reported | 06/30/2026 | 1249050966 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $118,901.38 | 07/23/2025 | Non-covered Recipient Entity UNIVERSITY OF SOUTHERN CALIFORNIA | A Phase III, Open-label, Randomised Study of Neoadjuvant Datopotamab Deruxtecan (Dato DXd) Plus Durvalumab Followed by Adjuvant Durvalumab With or Without Chemotherapy Versus Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab With or Without Chemotherapy for the Treatment of Adult Patients with Untreated Triple-Negative or Hormone Receptor low/HER2-negative Breast Cancer (TROPION Breast04) | No dispute reported | 06/30/2026 | 1185538194 |